Shelledy, Lindsay <br/><br/>
Vemurafenib: First-in-Class BRAF-Mutated Inhibitor for the Treatment of Unresectable or Metastatic Melanoma.  [electronic resource] 

 -  Journal of the advanced practitioner in oncology   
 - 361-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>2150-0878 
<br/><br/><label>Standard No.: </label>10.6004/jadpro.2015.6.4.6  doi